Guest: Ashish Atreja, MD, MPH

Dr. Ashish Atreja presents information about reimbursement for the EGD/Transoral Fundoplasty, which describes the TIF procedure with EsophyX device. He compares coding before and after January 2016, reviews available coverage, and the payments to providers and their facilities. Dr. Atreja is an Assistant Professor of Gastroenterology at Mount Sinai Hospital.

Guest: Kyle A. Perry, MD

Reflux is a tremendously common disorder that is not only costly, but significantly impacts patients’ quality of life. Join Dr. Kyle A. Perry as he reviews the TIF procedure and where it fits in the management of GERD, as well as patient selection for optimal outcomes. Dr. Perry is Associate Professor of Surgery and Co-Director of Research at the Center for Minimally Invasive Surgery at Ohio State University Wexner Medical Center. For more information, please visit EndoGastric Solutions at www.EndoGastricSolutions.com

Guest: Reginald C. W. Bell, MD, FACS

Dr. Reginald C.W. Bell recently presented at a live meeting that there is Level I and Level II evidence of durable control of regurgitation and atypical symptoms that can be achieved in specially selected population of GERD patients, which are patients partially responsive to PPIs and have a small hiatal hernia and good motility. In well-selected patients, TIF is a proven endoscopic alternative to other GERD therapies. With appropriate training and education, clinicians can ensure that the TIF procedure is done to obtain optimal outcomes. Dr. Bell is founder of the SurgOne Foregut Institute. For additional clinical data, please visit EndoGastric Solutions at http://www.endogastricsolutions.com/data/

Host: Barnett Mennen, MD

Guest: Mark Spitzer, MD

How are changes in technology influencing cervical cancer screening practices, and what is next for cervical cancer screening? Join host Dr. Barry Mennen as he and noted gynecologist Dr. Mark Spitzer discuss the natural history of cervical cancer and how screening guidelines are, and should be, informed by emerging evidence.

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG

Guest: Abigail Feathers, MD

Guest: Kevin J. Lee, MD, MSPH, FACOG

Guest: Stephen M. Volin, MD

In this discussion, host Dr. Renee Allen welcomes back gynecologic experts as they discuss "Endosee: Changing the Work Up of Abnormal Uterine Bleeding." They will review their experience on how Endosee benefits their individual practices, the benefits to their patients, and the overall healthcare system. Our medical guest experts are Dr. Abigail Feathers, solo practitioner, Medical and Surgical Gynecologist in Oakland, Maryland; Dr. Kevin J. Lee, minimally invasive GYN surgeon at MedStar Medical Group Women's Health at MedStar Good Samaritan Hospital in Baltimore, Maryland; and Dr. Stephen M. Volin, founder and managing partner of the Women's Health Group in Denver, Colorado. To listen to the first part of this discussion, please click here.

Host: Renée Simone Yolanda Allen, MD, MHSc., FACOG

Guest: Abigail Feathers, MD

Guest: Kevin J. Lee, MD, MSPH, FACOG

Guest: Stephen M. Volin, MD

Endometrial biopsy (EMB) has limitations in diagnosing abnormalities within the uterine cavity. If cancer occupies less than 50% of the surface are of the endometrial cavity, the cancer can be missed by a blind EMB alone. And, EMB alone could potentially miss the diagnosis of focal lesions in up to 18% of patients. In this first discussion of a 2-part series, experts will be discussing the benefits of direct visualization of the uterine cavity at the point of care and its benefits to both you and your patients. Host Dr. Renee Allen welcomes: Abigail Feathers, MD, Fellow of the American College of Obstetricians and Gynecologists (FACOG) and practicing gynecologist at Garrett Regional Medical Center, Oakland, MD. Kevin J. Lee, MD, MSPH, FACOG, practices minimally invasive gynecology and gynecologic endoscopy in Baltimore, MD. Dr. Lee has particular expertise and interest in uterine fibroids, abnormal uterine bleeding, pelvic pain, endometriosis, and health disparities. Stephen M. Volin, MD, founder and managing physician with The Women's Health Group and the Colorado Pelvic Floor and Incontinence Center, instructor with the University of Colorado School of Medicine and Rocky Vista University. To listen to the second part of this discussion, please click here.

Host: Barnett Mennen, MD

Guest: John C. Burnett Jr., MD

Host Barnett Mennen, MD welcomes John Burnett Jr, MD; Professor, Medicine and Physiology at the Mayo Clinic in Rochester, Minnesota, for an informative discussion about the roles of neurohormonal systems in heart failure. Dr. Burnett Jr. will discuss how an imbalance in key neurohormonal systems underlies the pathophysiology of heart failure and review the compensatory role that vasoactive peptides, including ones found in the natriuretic peptide system, play in heart failure. Please join us and listen! 5/16 HFS-1320843

Host: John J. Russell, MD

Guest: Ralph A. DeFronzo, MD

Leading Endocrinologist, Dr. Ralph A. DeFronzo joins host Dr. John Russell to discuss, "A Look at a GLP-1 Treatment Option for Adult Patients with Type 2 Diabetes" brought to you by AstraZeneca. Dr. DeFronzo will review BYETTA® (exenatide) injection, prescribing and usage guidelines; results of the 4B Study; and, potential risks and benefits of BYETTA. Dr. DeFronzo is Professor of Medicine, the Chief of the Diabetes Division at the University of Texas Health Science Center, and the Deputy Director of the Texas Diabetes Institute, San Antonio, Texas.

Brought to you by

Important Safety Information (ISI)

Contraindications

• BYETTA® (exenatide) injection is contraindicated in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components.

Warnings and Precautions

• Never Share a BYETTA Pen Between Patients: Pen-sharing poses a risk for transmission of blood-borne pathogens, even if the needle is changed.
• Pancreatitis: Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis ...

Host: Matt Birnholz, MD

Guest: Shantanu Agrawal, M.D.

For those who write prescriptions for patients who are a part of a Medicare Prescription Drug Plan (Part D), the time to enroll in Medicare is now! This timely program will provide insightful information about what you need to know in order to be ready for full enforcement on January 1, 2019. Join host Dr. Matt Birnholz as he speaks about Part D Prescriber Enrollment with Dr. Shantanu Agrawal, emergency medicine physician, and Deputy Administrator for Program Integrity, and Director of the Center for Program Integrity at the Centers for Medicare & Medicaid Services (CMS).

Host: Mario R. Nacinovich, Jr., MSc

Guest: Inderpal Randhawa, MD

What is the connection between allergies and asthma? And, why is allergy testing important in symptomatic patients? Host Mario R. Nacinovich Jr., MSc, Managing Partner at AXON Communications, welcomes Dr. Inderpal Randhawa, Associate Clinical Professor of Pediatrics, UC Irvine School of Medicine and Associate Clinical Professor of Medicine, UCLA David Geffen School of Medicine. In this expert interview sponsored by Quest Diagnostics, Dr. Randhawa will discuss the burden of asthma in the U.S., the challenge of adequately controlling asthma symptoms, the association between asthma and allergy or allergic triggers, and the use of NIH-approved IgE tests to diagnose allergen triggers.